- Report
- October 2024
- 193 Pages
Global
From €3389EUR$3,545USD£2,837GBP
€3766EUR$3,939USD£3,152GBP
- Report
- October 2024
- 195 Pages
Global
From €3389EUR$3,545USD£2,837GBP
€3766EUR$3,939USD£3,152GBP
- Report
- October 2024
- 185 Pages
Global
From €3389EUR$3,545USD£2,837GBP
€3766EUR$3,939USD£3,152GBP
- Report
- July 2024
- 100 Pages
Global
From €5689EUR$5,950USD£4,762GBP
- Report
- April 2025
- 354 Pages
Global
From €5354EUR$5,600USD£4,482GBP
- Report
- April 2023
- 110 Pages
Global
From €4541EUR$4,750USD£3,802GBP
- Report
- December 2022
- 118 Pages
Global
From €4302EUR$4,500USD£3,601GBP
Iron Dextran is a hematological drug used to treat iron deficiency anemia. It is a complex of iron and dextran, a polysaccharide, and is administered intravenously. Iron Dextran is used to replenish iron stores in the body, which are necessary for the production of hemoglobin, the oxygen-carrying component of red blood cells. Iron Dextran is also used to treat anemia caused by chronic kidney disease, chemotherapy, and other conditions.
Iron Dextran is available in both generic and branded forms. Common brand names include Dexferrum, INFeD, and Imferon. These products are manufactured by a variety of companies, including American Regent, Baxter, and Hospira. Show Less Read more